- Home
- TARA vs SANG Comparison
TARA vs SANG Comparison
Compare TARA & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARA | SANG |
|---|---|---|
| Founded | N/A | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 159.6M | 160.1M |
| IPO Year | 2014 | 2018 |
Fundamental Metrics
Financial Performance| Metric | TARA | SANG |
|---|---|---|
| Price | $2.34 | $4.67 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 8 | 4 |
| Target Price | ★ $25.71 | $5.50 |
| AVG Volume (30 Days) | ★ 1.3M | 303.8K |
| Earning Date | 11-09-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 38.25 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,948,000.00 | N/A |
| Revenue This Year | N/A | $3.23 |
| Revenue Next Year | N/A | $0.96 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.30 | $3.40 |
| 52 Week High | $7.82 | $5.42 |
Technical Indicators
Market Signals| Indicator | TARA | SANG |
|---|---|---|
| Relative Strength Index (RSI) | 29.64 | 58.59 |
| Support Level | N/A | $4.64 |
| Resistance Level | $4.13 | $4.76 |
| Average True Range (ATR) | 0.16 | 0.09 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 11.82 | 0.00 |
Price Performance
Historical ComparisonAbout TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is a clinical-stage biopharmaceutical company focused on advancing its therapies for the treatment of cancer and rare diseases. Its drug development pipeline includes: TARA-002, an investigational cell therapy in development for the treatment of non-muscle invasive bladder cancer (NMIBC) and lymphatic malformations (LMs); and IV Choline Chloride, an investigational phospholipid substrate replacement therapy, for patients receiving parenteral support, or PS, which includes both nutrition and fluids.
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic location USA and Other countries. Key revenue is generated from USA.